SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-013088
Filing Date
2017-06-29
Accepted
2017-06-29 06:01:06
Documents
3
Period of Report
2017-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prtk-8k_20170627.htm 8-K 45820
2 EX-4.1 prtk-ex41_6.htm EX-4.1 140515
3 EX-10.1 prtk-ex101_7.htm EX-10.1 82293
  Complete submission text file 0001564590-17-013088.txt   270169
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 17936671
SIC: 2834 Pharmaceutical Preparations